Study period | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Screening | Baseline | Follow-up | |||||||||||||
Time point (days) | − 1 | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | etc | 30th | Close-out |
Eligibility check | X | X | |||||||||||||
Informed consent | X | ||||||||||||||
Relevant medical history taken | X | X | |||||||||||||
Physical examination | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
Full blood count | X | X | X | X | |||||||||||
Lipid levels | X | X | X | X | |||||||||||
Liver and renal function | X | X | X | X | |||||||||||
Myocardial enzymes | X | X | X | X | |||||||||||
C-reactive protein | X | X | X | X | |||||||||||
Pro-BNP | X | X | X | X | |||||||||||
HBALC | X | X | X | X | |||||||||||
Electrocardiogram | X | X | X | X | |||||||||||
Echocardiography | X | X | X | X | |||||||||||
All-cause death | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
MACE | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |
Serious adverse events | X | X | X | X | X | X | X | X | X | X | X | X | X | X |